Joel Greenblatt Pacira Bio Sciences, Inc. Transaction History
Gotham Asset Management, LLC
- $7.56 Billion
- Q2 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 28,928 shares of PCRX stock, worth $506,240. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,928
Previous 13,541
113.63%
Holding current value
$506,240
Previous $395,000
109.37%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding PCRX
# of Institutions
273Shares Held
48.6MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$140 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$89 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$86.8 Million0.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$36.2 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$33.3 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $802M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...